CIMT Testing for Stroke Prevention: Why Blood Pressure Isn't Enough

Blood pressure control is important. But new research shows it might not be enough—and that's why I always use the CIMT to catch stroke risk that other tests miss.

I talk to patients every day who tell me: "My blood pressure is fine." And that's good. But here's what I've learned: having normal blood pressure doesn't mean your arteries are healthy.

A study that really stuck with me followed over 1,600 Black adults from the Jackson Heart Study for more than 14 years. None of them had a history of cardiovascular disease at the start. They tracked everything—blood pressure, CIMT measurements, stroke events. What they found should change how we think about stroke prevention.[^1]

What Did the Research Actually Find?

Every 0.17 mm increase in CIMT raised stroke risk by about 30%. That's a significant jump from what seems like a small change in artery wall thickness.

But here's what really got my attention: this held true even for people with well-controlled blood pressure. Even with systolic BP under 120 mm Hg—the gold standard for control—those with thicker artery walls had up to a 56% higher odds of stroke. Normal blood pressure didn't protect them.

People with the thickest artery walls (CIMT above 0.84 mm) had substantially higher stroke rates compared to those with the thinnest walls. That's not a small difference. That's a red flag.[^1]

Why Isn't Blood Pressure Control Enough?

Think about what blood pressure actually does. It pushes against your artery walls, day after year. Even when those numbers look good on paper, the damage accumulates. Your arteries experience "wear and tear" that doesn't show up on a blood pressure cuff.

High blood pressure doesn't just stress the arteries directly—it triggers inflammatory and structural changes in artery walls over time. CIMT measures the end result of that damage: actual wall thickening. So yes, control your blood pressure. But know this: even well-controlled blood pressure leaves residual risk that CIMT can reveal.[^2]

The American Heart Association's 2023 statistics underscore the scale of this problem: stroke remains a leading cause of death and long-term disability in the U.S., disproportionately affecting Black adults and those with hypertension.[^3]

What Happens When a Patient Doesn't Wait for a Wake-Up Call?

Maria was 52 when she came to Renew Health. She considered herself healthy—she exercised regularly, ate reasonably well, and her primary care provider had never raised concerns. Her cholesterol was "borderline but acceptable" and her blood pressure was normal.

When we did her CIMT test, we found something alarming: soft plaque buildup in her carotid arteries with an IMT measurement of 0.82 mm—well above the healthy threshold of 0.50 mm. Her arterial age calculated to 67 years—15 years older than her chronological age.

The critical insight: Standard cardiology would have told Maria she was fine. Her risk score would have placed her in a low-to-intermediate category. But CIMT detected silent, dangerous soft plaque—the type responsible for most heart attacks and strokes—years before it would have shown up on any other test.

With this information, we initiated an aggressive but targeted prevention plan: therapy to address the inflammation driving her plaque, supplements to support arterial health, and dietary modifications. Within 18 months, follow-up CIMT imaging showed measurable improvement—her plaque had stabilized and her arterial age dropped.

That's the thing about stroke: it often doesn't give you warning signs. Maria's story is exactly why I recommend CIMT for anyone with risk factors—even if their blood pressure looks great.

How Does CIMT Improve Risk Prediction?

The same Jackson Heart Study also looked at how CIMT improves standard risk prediction. The researchers added it to the Pooled Cohort Equations (PCE)—the standard model doctors use to estimate 10-year cardiovascular risk.

The results were striking. Among low-to-borderline risk participants who actually had strokes, 58% were correctly reclassified into a higher-risk category when CIMT was added. And 28% of those who didn't have strokes were appropriately moved to a lower-risk group—meaning we're not over-treating people either.[^1]

A separate large meta-analysis of over 45,000 patients across 14 cohort studies found that adding CIMT to standard risk models improved reclassification across both men and women—providing the strongest benefit in intermediate-risk individuals where the treatment decision is hardest to make.[^4]

The bottom line: CIMT finds people who would otherwise fly under the radar, and it avoids overtreating those who are truly at low risk.

Who Should Consider Getting a CIMT Test?

If you've been told your cardiovascular risk is "low" or "borderline," and you have any of these factors, CIMT might tell a different story:

• Family history of stroke or heart attack
• Diabetes or pre-diabetes
• Metabolic syndrome (even with normal blood pressure)
• Smoking history
• Age over 45

The test takes 30–45 minutes. No radiation, no contrast, no pain—just an ultrasound probe on your neck. What we get is a direct window into the health of your arteries.

How Do You Interpret Your CIMT Results?

Here's how we interpret CIMT measurements:

| IMT Value | Risk Level | What It Means | |-----------|------------|---------------| | Less than 0.50 mm | Low | Healthy artery walls | | 0.50–0.75 mm | Moderate | Some wear—lifestyle changes recommended | | Greater than 0.75 mm | High | Significant thickening—aggressive intervention warranted |

When we detect plaque, we also classify the type:

• Soft plaque — Most dangerous, often invisible on other tests
• Heterogeneous plaque — Mixed composition
• Calcified plaque — Hardened, easier to see but indicates advanced disease

What Else Can You Do to Lower Stroke Risk?

CIMT is one piece of the puzzle. Here's what else matters:

Lower blood pressure — This is still the single most important thing. Aim for under 120/80, though some people do better with slightly higher targets.

Maintain a healthy weight — Obesity raises stroke risk by increasing blood pressure and diabetes risk. Losing even 10 pounds helps.

Exercise regularly — Moderate activity at least five days a week keeps blood vessels flexible and improves flow.

Limit alcohol — More than two drinks a day for men, one for women, raises blood pressure and stroke risk.

Control diabetes — High blood sugar damages blood vessels over time. Keep your levels in check.

Quit smoking — Smoking thickens blood and contributes to plaque buildup. This is one of the most effective changes you can make.

The Bottom Line

I've seen too many patients surprised by strokes who "did everything right." They controlled their blood pressure, exercised, ate reasonably well. But nobody ever checked what was happening inside their arteries.

That's where CIMT changes the game. It finds the hidden damage that blood pressure cuffs and cholesterol tests can't see.

If you're over 45—or younger with risk factors—ask about CIMT. It's a simple test that gives you and your doctor information that could literally save your life.

---

Ready to understand your real stroke risk? Schedule a CIMT test and see what's actually happening in your arteries. Or review our pricing and packages to find the right fit for you.

---

Related articles:

• Biomarkers of Aging and Cardiovascular Risk
• Heart Attack and Stroke Risk Factors: What Everyone Over 50 Should Know
• CIMT vs. CT Calcium Scoring: Which Test Is Right for You?

---

[^1]: Abe TA, Olanipekun T, Yan F, et al. "Carotid Intima-Media Thickness and Improved Stroke Risk Assessment in Hypertensive Black Adults." Am J Hypertens. 2024;37(4):290-297. doi:10.1093/ajh/hpae008. PMID: 38236147. https://pubmed.ncbi.nlm.nih.gov/38236147/

[^2]: Abe TA, et al. Am J Hypertens. 2024. Among participants with systolic blood pressure <120 mm Hg, each 0.17 mm increase in cIMT was associated with up to 56% higher odds of stroke, demonstrating residual vascular risk even with well-controlled hypertension.

[^3]: Tsao CW, Aday AW, Almarzooq ZI, et al. "Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association." Circulation. 2023;147(8):e93-e621. doi:10.1161/CIR.0000000000001123. PMID: 36695182.

[^4]: Den Ruijter HM, Peters SA, Anderson TJ, et al. "Common Carotid Intima-Media Thickness Measurements in Cardiovascular Risk Prediction: A Meta-Analysis." JAMA. 2012;308(8):796-803. doi:10.1001/jama.2012.9630. PMID: 22910757. https://pubmed.ncbi.nlm.nih.gov/22910757/